The protective effects of dexmedetomidine on hepatic ischemia reperfusion injury
dc.contributor.author | Kucuk A. | |
dc.contributor.author | Yaylak F. | |
dc.contributor.author | Cavunt-Bayraktar A. | |
dc.contributor.author | Tosun M. | |
dc.contributor.author | Arslan M. | |
dc.contributor.author | Comu F.M. | |
dc.contributor.author | Kavutcu M. | |
dc.date.accessioned | 2020-06-25T15:17:32Z | |
dc.date.available | 2020-06-25T15:17:32Z | |
dc.date.issued | 2014 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description.abstract | Objective: The aim of this study was to evaluate the effect of dexmedetomidine (100 ?g/kg-ip) on liver ischemia and reperfusion (I/R) in rats. Methods: Twenty-four Wistar Albino rats were separated into three groups as control (C), ischemia-reperfusion injury (I/R) and dexmedetomidine group (I/R-D). Ischemia was induced with portal clampage for 45 minutes and reperfusion period was 45 minutes after declampage. Group I/R-D was received dexmedetomidine 100 ?g/ kg i.p. 30 min before portal clampage. Thiobarbutiric Acid-Reactive Substances (TBARS), glutathioneS-transferase (GST), superoxide dismutase (SOD), Catalase (CAT), and Paraoxonase 1 (PON-1) were investigated in blood samples. Also HSP60 and p53-positive hepatocytes were counted under ImageJ image analysis program. Results: All parameters, except GST levels, were significant between the groups (p < 0.05). Although HSP60 expression was significantly increased between I/R, I/R-D and C groups there were no significant differences between I/R-D and C (p = 0.443). On the other hand, p53 expression was also significantly increased between I/R, I/R-D and C groups At the same time, there were no significant differences between I/R-D and C groups (p = 0.354). Conclusion: All the results suggest that dexmedetomidine has beneficial effects on liver ischemia/reperfusion stress. | en_US |
dc.identifier.doi | 10.4149/BLL_2014_132 | |
dc.identifier.endpage | 684 | en_US |
dc.identifier.issn | 00069248 | |
dc.identifier.issue | 11 | en_US |
dc.identifier.pmid | 25428535 | |
dc.identifier.scopus | 2-s2.0-84915825911 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 680 | en_US |
dc.identifier.uri | https://doi.org/10.4149/BLL_2014_132 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/2414 | |
dc.identifier.volume | 115 | en_US |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Comenius University | en_US |
dc.relation.ispartof | Bratislava Medical Journal | |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Dexmedetomidine | en_US |
dc.subject | HSP60 | en_US |
dc.subject | Ischemia reperfusion | en_US |
dc.subject | p53 | en_US |
dc.subject | Rat | en_US |
dc.title | The protective effects of dexmedetomidine on hepatic ischemia reperfusion injury | en_US |
dc.type | Article |